OBJ is being valued much much higher... HTX has an actual dollar value agreement in place. and remember the ovarian cancer space is a difficult one when it comes to diagnosis and a superior product is much valued.
the fact is a lot of tipsheets were touting this one for aeons.. they must really like the potential.
$21m profit but $13m market cap - announcement, page-10
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
